236 related articles for article (PubMed ID: 20055482)
1. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.
Lu H; Tonge PJ
Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482
[TBL] [Abstract][Full Text] [Related]
2. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
3. Determination of the crystal structure and active residues of FabV, the enoyl-ACP reductase from Xanthomonas oryzae.
Li H; Zhang X; Bi L; He J; Jiang T
PLoS One; 2011; 6(10):e26743. PubMed ID: 22039545
[TBL] [Abstract][Full Text] [Related]
4. Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase.
Zhu L; Lin J; Ma J; Cronan JE; Wang H
Antimicrob Agents Chemother; 2010 Feb; 54(2):689-98. PubMed ID: 19933806
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and structural characterization of the trans-enoyl-CoA reductase from Treponema denticola.
Bond-Watts BB; Weeks AM; Chang MC
Biochemistry; 2012 Aug; 51(34):6827-37. PubMed ID: 22906002
[TBL] [Abstract][Full Text] [Related]
6. Structure of the Yersinia pestis FabV enoyl-ACP reductase and its interaction with two 2-pyridone inhibitors.
Hirschbeck MW; Kuper J; Lu H; Liu N; Neckles C; Shah S; Wagner S; Sotriffer CA; Tonge PJ; Kisker C
Structure; 2012 Jan; 20(1):89-100. PubMed ID: 22244758
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of Pyridone- and Diphenyl Ether-Based Inhibitors for the Yersinia pestis FabV Enoyl-ACP Reductase.
Neckles C; Pschibul A; Lai CT; Hirschbeck M; Kuper J; Davoodi S; Zou J; Liu N; Pan P; Shah S; Daryaee F; Bommineni GR; Lai C; Simmerling C; Kisker C; Tonge PJ
Biochemistry; 2016 May; 55(21):2992-3006. PubMed ID: 27136302
[TBL] [Abstract][Full Text] [Related]
8. Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei.
Liu N; Cummings JE; England K; Slayden RA; Tonge PJ
J Antimicrob Chemother; 2011 Mar; 66(3):564-73. PubMed ID: 21393229
[TBL] [Abstract][Full Text] [Related]
9. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
Heath RJ; Su N; Murphy CK; Rock CO
J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and Structural Basis of Triclosan Resistance in a Novel Enoyl-Acyl Carrier Protein Reductase.
Khan R; Zeb A; Roy N; Thapa Magar R; Kim HJ; Lee KW; Lee SW
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891603
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of Enoyl-ACP reductases I (FabI) and III (FabL) from B. subtilis.
Kim KH; Ha BH; Kim SJ; Hong SK; Hwang KY; Kim EE
J Mol Biol; 2011 Feb; 406(3):403-15. PubMed ID: 21185310
[TBL] [Abstract][Full Text] [Related]
12. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.
Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA
Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
Hoang TT; Schweizer HP
J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and Structural Insights Concerning Triclosan Resistance in a Novel YX
Khan R; Zeb A; Choi K; Lee G; Lee KW; Lee SW
Sci Rep; 2019 Oct; 9(1):15401. PubMed ID: 31659200
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.
Lee JH; Park AK; Chi YM; Moon JH; Lee KS
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):214-6. PubMed ID: 21301088
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant.
Lee IH; Kim EJ; Cho YH; Lee JK
Biochem Biophys Res Commun; 2002 Dec; 299(4):621-7. PubMed ID: 12459184
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitor.
Saito J; Yamada M; Watanabe T; Iida M; Kitagawa H; Takahata S; Ozawa T; Takeuchi Y; Ohsawa F
Protein Sci; 2008 Apr; 17(4):691-9. PubMed ID: 18305197
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.
Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW
Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
